Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure
- Registration Number
- NCT00057356
- Lead Sponsor
- Cumberland Pharmaceuticals
- Brief Summary
This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine the effects of conivaptan in patients with acute decompensated heart failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 170
- Patients may be male or female age 18 years or older.
- Women must be post-menopausal or surgically sterile.
- Patients must have chronic heart failure of at least 2 months duration and be hospitalized for the treatment of worsening heart failure. The primary manifestation of worsening heart failure must be worsening dyspnea.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 placebo - 2 conivaptan Low dose 4 conivaptan High dose 3 conivaptan Middle dose
- Primary Outcome Measures
Name Time Method Change from baseline in respiratory Visual analog Scale (VAS) 48 hours
- Secondary Outcome Measures
Name Time Method Change from baseline in global VAS 48 hours Total urine output vs. baseline 72 hours
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (26)
The Heart Center, P.C.
🇺🇸Huntsville, Alabama, United States
LA County/USC Medical Center
🇺🇸Los Angeles, California, United States
San Joaquin Cardiology
🇺🇸Manteca, California, United States
Apex Research Institute
🇺🇸Santa Ana, California, United States
The Greater Fort Lauderdale Heart Group Research
🇺🇸Fort Lauderdale, Florida, United States
Jacksonville Center for Clinical Research
🇺🇸Jacksonville, Florida, United States
U. Miami, Jackson Mem'l Medical Center
🇺🇸Miami, Florida, United States
Discovery Medical Research Group
🇺🇸Ocala, Florida, United States
Rush-Presbyterian St. Luke's Medical Center
🇺🇸Chicago, Illinois, United States
Louisiana State University Medical Center School of Medicine
🇺🇸New Orleans, Louisiana, United States
Scroll for more (16 remaining)The Heart Center, P.C.🇺🇸Huntsville, Alabama, United States